These research projects have been completed.
Principal Investigator: Schwamm, Lee H., M.D. End Date: January 2007 Summary: DIAS-2 was a prospective, randomized, double-Blind, placebo-Controlled, single Bolus, multinational, multicenter, parallel group, dose-ranging study of desmoteplase (INN) in the indication of acute stroke. Massachusetts General Hospital was the participating site for this trial and was a highest enrolling site in North America.
Online Publications
Principal Investigator: Rordorf, Guy A., M.D. Summary: Study of efficacy of induced hypertension to improve neurologic deficit in acute stroke patients by increasing brain blood flow.
Principal Investigators: Gazelle, Scott, M.D., Ph.D., Furie, Karen, M.D., Gleason, Suzanne, Ph.D., and Koroshetz, Walter J., M.D. Summary: Center for Innovative and Minimally Invasive Therapy/ Department of Defense funded study of the cost of stroke and the benefit that may accrue from new therapies to reduce disability.
Principal Investigators: Greenberg, Steven, M.D., Ph.D., Furie, Karen, M.D., and Stein, Joel, M.D. Start Date: November 1999 End Date: October 31, 2003
Principal Investigators: Furie, Karen, M.D. and Kistler, Philip, M.D. Summary: NIH sponsored randomized double-blind placebo-controlled trial of family intervention in stroke recovery.
Principal Investigator: Moskowitz, Michael, M.D. Summary:Goal is to better understand the molecular mechanisms that underlie ischemic stroke.
Thank you for e-mailing this page.
Thank you for your providing feedback. Your comments will be responded to within an appropriate time frame.
Save & Share this webpage
The MGH Neurology Department placed 4th in US News Neurology / NeuroSurgery rankings for 2007.
Support the Stroke Service
This video simulation of an Emergency stroke evaluation illustrates the care of patients with acute stroke by the MGH Acute Stroke team.
Most frequently visited pages